Request Appointment
17183 Interstate 45Suite 110The Woodlands, TX 77385
Overview of Dr. Guerrero
Dr. Thomas Guerrero is an oncologist in The Woodlands, TX and is affiliated with multiple hospitals in the area, including Houston Methodist The Woodlands Hospital, Phelps Health, and Harry S. Truman Memorial Veterans' Hospital. He received his medical degree from Universidad de Guayaquil, School of Medicine. and has been in practice 10 years. He is one of 6 doctors at Phelps Health and one of 40 doctors at Harry S. Truman Memorial Veterans' Hospital who specialize in Oncology. He has more than 10 publications and over 200 citings.
Education & Training
St Elizabeth's Medical CenterFellowship, Hematology and Medical Oncology, 2017
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 2012 - 2014
Universidad de Guayaquil, School of Medicine.Class of 2007
Certifications & Licensure
TX State Medical License 2025 - 2027
MO State Medical License 2019 - 2026
MA State Medical License 2014 - 2019
RI State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Multi-institutional, randomized, controlled trial to assess the efficacy and tolerability of a reusable, self-contained cryotherapy delivery device.Richard Zuniga, Vikas Dembla, Naheed Alam, Chaitali Nangia, Thomas Guerrero-Garcia
Supportive Care in Cancer. 2025-07-31 - 16 citationsA prognostic index predicting survival in transformed Waldenström macroglobulinemia.Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, Efstathios Kastritis, Shirley D'Sa
Haematologica. 2020-11-12 - 65 citationsBortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.Jorge J. Castillo, Thomas Guerrero-Garcia, Francesco Baldini, Emmanuelle Tchernonog, Guillaume Cartron
British Journal of Haematology. 2019-02-01
Abstracts/Posters
- Circulating Tumor DNA in the Peripheral Blood As Early Predictor of Clinical Outcome in Relapsed/ Refractory Multiple MyelomaThomas Guerrero, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Defining the Differentiation States of Multiple Myeloma at Single Cell Resolution Reveals Opportunities for ImmunotherapyThomas Guerrero, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
